Affiliated Managers Group (AMG)
(Real Time Quote from BATS)
$160.03 USD
-2.04 (-1.26%)
Updated Apr 25, 2024 03:14 PM ET
2-Buy of 5 2
A Value F Growth B Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
AMG 160.03 -2.04(-1.26%)
Will AMG be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for AMG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AMG
Pick These 5 Low Price-to-Sales Stocks to Stay Profitable
Are Investors Undervaluing AllianceBernstein (AB) Right Now?
AMG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Kinsale Capital Group (KNSL) Stock Outpacing Its Finance Peers This Year?
Why Affiliated Managers Group (AMG) is a Top Value Stock for the Long-Term
Why Affiliated Managers Group (AMG) is a Top Value Stock for the Long-Term
Other News for AMG
Third Avenue Real Estate Value UCITS Named Best Global Real Estate Fund by LSEG Lipper
Piper Sandler Sticks to Its Buy Rating for Amgen (AMGN)
Affiliated Managers Group Is Undervalued Against Peer Group
Analyst Holds on Amgen’s Tezspire amid COPD Trial Uncertainties and Pending Competitor Comparisons
Buy Rating on Amgen: Tezspire’s Market Potential in COPD Treatment Undervalued